Bragg Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Buy |
13,103
+595
| +5% | +$464K | 0.36% | 99 |
|
|
2025
Q1 | $10.3M | Buy |
12,508
+495
| +4% | +$409K | 0.42% | 90 |
|
|
2024
Q4 | $9.27M | Buy |
12,013
+397
| +3% | +$306K | 0.38% | 103 |
|
|
2024
Q3 | $10.3M | Buy |
11,616
+592
| +5% | +$524K | 0.42% | 92 |
|
|
2024
Q2 | $9.98M | Buy |
11,024
+906
| +9% | +$820K | 0.45% | 91 |
|
|
2024
Q1 | $7.87M | Buy |
10,118
+2,463
| +32% | +$1.92M | 0.35% | 104 |
|
|
2023
Q4 | $4.46M | Buy |
7,655
+5,631
| +278% | +$3.28M | 0.21% | 128 |
|
|
2023
Q3 | $1.09M | Sell |
2,024
-52
| -3% | -$27.9K | 0.06% | 194 |
|
|
2023
Q2 | $974K | Sell |
2,076
-22
| -1% | -$10.3K | 0.05% | 199 |
|
|
2023
Q1 | $720K | Sell |
2,098
-11
| -0.5% | -$3.78K | 0.04% | 215 |
|
|
2022
Q4 | $772K | Buy |
2,109
+151
| +8% | +$55.2K | 0.05% | 209 |
|
|
2022
Q3 | $633K | Sell |
1,958
-35
| -2% | -$11.3K | 0.04% | 205 |
|
|
2022
Q2 | $646K | Hold |
1,993
| – | – | 0.04% | 202 |
|
|
2022
Q1 | $571K | Buy |
1,993
+214
| +12% | +$61.3K | 0.03% | 225 |
|
|
2021
Q4 | $411K | Hold |
1,779
| – | – | 0.03% | 243 |
|
|
2021
Q3 | $411K | Hold |
1,779
| – | – | 0.03% | 243 |
|
|
2021
Q2 | $408K | Hold |
1,779
| – | – | 0.03% | 243 |
|
|
2021
Q1 | $332K | Buy |
1,779
+23
| +1% | +$4.29K | 0.02% | 251 |
|
|
2020
Q4 | $296K | Hold |
1,756
| – | – | 0.03% | 246 |
|
|
2020
Q3 | $260K | Buy |
+1,756
| New | +$260K | 0.03% | 242 |
|